Skip to main content Accessibility help
×
Home
Hostname: page-component-7bb4899584-6p6dm Total loading time: 0.681 Render date: 2023-01-27T01:03:12.737Z Has data issue: true Feature Flags: { "useRatesEcommerce": false } hasContentIssue true

Chapter 13 - Familial hepatocellular cholestasis

from Section II - Cholestatic liver disease

Published online by Cambridge University Press:  05 March 2014

Frederick J. Suchy
Affiliation:
University of Colorado Medical Center
Shikha S. Sundaram
Affiliation:
Section of Gastroenterology, Hepatology and Nutrition, Children’s Hospital Colorado and University of Colorado School of Medicine, Aurora, CO, USA
Benjamin L. Shneider
Affiliation:
Pediatric Hepatology, University of Pittsburgh, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
Frederick J. Suchy
Affiliation:
University of Colorado Medical Center
Ronald J. Sokol
Affiliation:
University of Colorado Medical Center
William F. Balistreri
Affiliation:
University of Cincinnati College of Medicine
Get access

Summary

Introduction

Inherited cholestasis of hepatocellular origin has long been described in the neonate or during the first year of life [1]. Many of these infants were categorized as having idiopathic neonatal hepatitis after biliary atresia, metabolic diseases, and congenital infections were excluded [2,3]. The prognosis in familial cholestasis was poor compared with sporadic cholestasis that sometimes had an identifiable etiology. As the clinical and genotypic heterogeneity of these inherited disorders has become apparent, it is now recognized that patients may present initially and progress to end-stage liver disease at ages ranging from infancy to adulthood [4]. There may be significant overlap in clinical features such as intense pruritus and a low serum concentration of gamma-glutamyltransferase (GGT). The histopathology, immunohistochemical staining, and hepatic ultrastructure may provide additional diagnostic clues as to the underlying defect. However, the identification of the genes responsible for several of these disorders now allows a specific diagnosis in many cases, may suggest therapy with varying success based on the genotype of the patient, and has advanced our understanding of molecular mechanisms of bile secretion and acquired cholestasis. It is not surprising that, so far, mutations in three genes encoding ATP-dependent transport proteins localized to the canalicular membrane that result in progressive cholestasis and liver injury have been discovered. The features of these disorders are compared in Table 13.1. Other genes encoding proteins involved in membrane transport, vesicular trafficking, and integrity of the cell junction may also be mutated in some patients. Owing to an immaturity of hepatic excretory function, cholestasis may occasionally occur in inherited diseases because of systemic illness rather than a primary defect in the liver (see Table 9.1). These disorders will not be considered in this review.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Clayton, RJ, Iber, FL, Ruebner, BH, McKusick, VA. Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred. J. Pediatr 1965;67:1025–1028.CrossRefGoogle Scholar
Summerskill, WHJ, Walshe, JM. Benign recurrent intrahepatic “obstructive” jaundice. Lancet 1959;ii:686–690.CrossRefGoogle Scholar
Carlton, VEH, Knisely, AS, Freimer, NB. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region. Hum Mol Genet 1995;4:1049–1053.CrossRefGoogle ScholarPubMed
van Mil, SW, Klomp, LW, Bull, LN, Houwen, RH. FIC1 disease: a spectrum of intrahepatic cholestatic disorders. Semin Liver Dis 2001;21:535–544.CrossRefGoogle ScholarPubMed
Klomp, LW, Vargas, JC, van Mil, SW, et al. Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology 2004;40:27–38.CrossRefGoogle ScholarPubMed
Pawlikowska, L, Strautnieks, S, Jankowska, I, et al. Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol 2010;53:170–178.CrossRefGoogle ScholarPubMed
Davit-Spraul, A, Fabre, M, Branchereau, S, et al. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology 2010;51:1645–1655.CrossRefGoogle ScholarPubMed
Miyagawa-Hayashino, A, Egawa, H, Yorifuji, T, et al. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation. Liver Transpl 2009;15:610–618.CrossRefGoogle ScholarPubMed
Luketic, VA, Shiffman, ML. Benign recurrent intrahepatic cholestasis. Clin Liver Dis 2004;8:133–149, vii.CrossRefGoogle ScholarPubMed
Morotti, RA, Suchy, FJ, Magid, MS. Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings. Semin Liver Dis 2011;31:3–10.CrossRefGoogle ScholarPubMed
Knisely, AS, Gissen, P. Trafficking and transporter disorders in pediatric cholestasis. Clin Liver Dis 2010;14:619–633.CrossRefGoogle ScholarPubMed
Bull, LN, van Eijk, MJT, Pawlikowska, L, et al. Identification of a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998;18:219–224.CrossRefGoogle Scholar
Frankenberg, T, Miloh, T, Chen, FY, et al. The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor. Hepatology 2008;48:1896–1905.CrossRefGoogle Scholar
van der Velden, LM, Stapelbroek, JM, Krieger, E, et al. Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate. Hepatology 2010;51:286–296.CrossRefGoogle ScholarPubMed
Pawlikowska, L, Groen, A, Eppens, EF, et al. A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. Hum Mol Genet 2004;13:881–892.CrossRefGoogle ScholarPubMed
Groen, A, Kunne, C, Paulusma, CC, et al. Intestinal bile salt absorption in Atp8b1 deficient mice. J Hepatol 2007;47:114–122.CrossRefGoogle ScholarPubMed
Paulusma, CC, Groen, A, Kunne, C, et al. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology 2006;44:195–204.CrossRefGoogle ScholarPubMed
Stapelbroek, JM, Peters, TA, van Beurden, DH, et al. ATP8B1 is essential for maintaining normal hearing. Proc Natl Acad Sci USA 2009;106:9709–9714.CrossRefGoogle ScholarPubMed
Ray, NB, Durairaj, L, Chen, BB, et al. Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia. Nat Med 2010;16:1120–1127.CrossRefGoogle ScholarPubMed
Ujhazy, P, Ortiz, D, Misra, S, et al. Familial intrahepatic cholestasis 1: studies of localization and function. Hepatology 2001;34:768–775.CrossRefGoogle ScholarPubMed
Paulusma, CC, Folmer, DE, Ho-Mok, KS, et al. ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity. Hepatology 2008;47:268–278.CrossRefGoogle ScholarPubMed
Paulusma, CC, de Waart, DR, Kunne, C, Mok, KS, Elferink, RP. Activity of the bile salt export pump (ABCB11) is critically dependent on canalicular membrane cholesterol content. J Biol Chem 2009;284:9947–9954.CrossRefGoogle ScholarPubMed
Groen, A, Romero, MR, Kunne, C, et al. Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity. Gastroenterology 2011;141:1927–37 e1–4.CrossRefGoogle ScholarPubMed
Verhulst, PM, van der Velden, LM, Oorschot, V, et al. A flippase-independent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells. Hepatology 2010;51:2049–2060.CrossRefGoogle ScholarPubMed
van Mil, SW, van Oort, MM, van den Berg, IE, et al. Fic1 is expressed at apical membranes of different epithelial cells in the digestive tract and is induced in the small intestine during postnatal development of mice. Pediatr Res 2004;56:981–987.CrossRefGoogle Scholar
Chen, F, Ananthanarayanan, M, Emre, S, et al. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 2004;126:756–764.CrossRefGoogle ScholarPubMed
Chen, F, Ellis, E, Strom, SC, Shneider, BL. ATPase class I type 8B member 1 and protein kinase Czeta induce the expression of the canalicular bile salt export pump in human hepatocytes. Pediatr Res 2010;67:183–187.CrossRefGoogle Scholar
Strautnieks, SS, Byrne, JA, Pawlikowska, L, et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 2008;134:1203–1214.CrossRefGoogle ScholarPubMed
Lam, P, Soroka, CJ, Boyer, JL. The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease. Semin Liver Dis 2010;30:125–133.CrossRefGoogle ScholarPubMed
Jansen, PL, Strautnieks, SS, Jacquemin, E, et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999;117:1370–1379.CrossRefGoogle ScholarPubMed
Davit-Spraul, A, Gonzales, E, Baussan, C, Jacquemin, E. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis 2009;4:1.CrossRefGoogle ScholarPubMed
Alissa, FT, Jaffe, R, Shneider, BL. Update on progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 2008;46:241–252.CrossRefGoogle ScholarPubMed
Dixon, PH, Weerasekera, N, Linton, KJ, et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000;9:1209–1217.CrossRefGoogle ScholarPubMed
Thompson, R, Strautnieks, S. BSEP: function and role in progressive familial intrahepatic cholestasis. Semin Liver Dis 2001;21:545–550.CrossRefGoogle ScholarPubMed
Byrne, JA, Strautnieks, SS, Ihrke, G, et al. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology 2009;49:553–567.CrossRefGoogle ScholarPubMed
Kurbegov, AC, Setchell, KD, Haas, JE, et al. Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile. Gastroenterology 2003;125:1227–1234.CrossRefGoogle ScholarPubMed
Whitington, PF, Whitington, GL. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology 1988;95:130–136.CrossRefGoogle ScholarPubMed
Stapelbroek, JM, van Erpecum, KJ, Klomp, LW, et al. Nasobiliary drainage induces long-lasting remission in benign recurrent intrahepatic cholestasis. Hepatology 2006;43:51–53.CrossRefGoogle ScholarPubMed
Shneider, BL. Liver transplantation for progressive familial intrahepatic cholestasis: the evolving role of genotyping. Liver Transplant 2009;15:565–566.CrossRefGoogle ScholarPubMed
Jara, P, Hierro, L, Martinez-Fernandez, P, et al. Recurrence of bile salt export pump deficiency after liver transplantation. N Engl J Med 2009;361:1359–1367.CrossRefGoogle ScholarPubMed
Siebold, L, Dick, AA, Thompson, R, et al. Recurrent low gamma-glutamyl transpeptidase cholestasis following liver transplantation for bile salt export pump (BSEP) disease (posttransplant recurrent BSEP disease). Liver Transplant 2010;16:856–863.CrossRefGoogle Scholar
Davit-Spraul, A, Gonzales, E, Baussan, C, Jacquemin, E. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. Semin Liver Dis 2010;30:134–146.CrossRefGoogle ScholarPubMed
Morotti, RA, Suchy, FJ, Magid, MS. Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings. Semin Liver Dis 2011;31:3–10.CrossRefGoogle ScholarPubMed
Sundaram, SS, Sokol, RJ. The Multiple facets of ABCB4 (MDR3) deficiency. Curr Treat Options Gastroenterol 2007;10:495–503.CrossRefGoogle ScholarPubMed
Jacquemin, E, De Vree, JM, Cresteil, D, et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001;120:1448–1458.CrossRefGoogle ScholarPubMed
Rosmorduc, O, Hermelin, B, Poupon, R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001;120:1459–1467.CrossRefGoogle ScholarPubMed
Lucena, JF, Herrero, JI, Quiroga, J, et al. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 2003;124:1037–1042.CrossRefGoogle ScholarPubMed
Jacquemin, E, Cresteil, D, Manouvrier, S, Boute, O, Hadchouel, M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999;353:210–211.CrossRefGoogle ScholarPubMed
Schneider, G, Paus, TC, Kullak-Ublick, GA, et al. Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy. Hepatology 2007;45:150–158.CrossRefGoogle ScholarPubMed
Ziol, M, Barbu, V, Rosmorduc, O, et al. ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults. Gastroenterology 2008;135:131–141.CrossRefGoogle ScholarPubMed
Smit, JJ, Schinkel, AH, Oude Elferink, RP, et al. Homozygous disruption of the murine Mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993;75:451–462.CrossRefGoogle ScholarPubMed
Small, DM. Role of ABC transporters in secretion of cholesterol from liver into bile. Proc Natl Acad Sci USA 2003;100:4–6.CrossRefGoogle ScholarPubMed
Fickert, P, Fuchsbichler, A, Wagner, M, et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 2004;127:261–274.CrossRefGoogle ScholarPubMed
Binder, T, Salaj, P, Zima, T, Vitek, L. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med 2006;34:383–391.CrossRefGoogle ScholarPubMed
Drivdal, M, Trydal, T, Hagve, TA, Bergstad, I, Aagenaes, O. Prognosis, with evaluation of general biochemistry, of liver disease in lymphoedema cholestasis syndrome 1 (LCS1/Aagenaes syndrome). Scand J Gastroenterol 2006;41:465–471.CrossRefGoogle Scholar
Aagenaes, O. Hereditary cholestasis with lymphoedema (Aagenaes syndrome, cholestasis-lymphoedema syndrome). New cases and follow-up from infancy to adult age. Scand J Gastroenterol 1998;33:335–345.CrossRefGoogle ScholarPubMed
Nezelof, C, Dupart, MC, Jaubert, F, Eliachar, E. A lethal familial syndrome associating arthrogryposis multiplex congenita, renal dysfunction, and a cholestatic and pigmentary liver disease. J Pediatr 1979;94:258–260.CrossRefGoogle Scholar
Gissen, P, Johnson, CA, Morgan, NV, et al. Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis–renal dysfunction–cholestasis (ARC) syndrome. Nat Genet 2004;36:400–404.CrossRefGoogle ScholarPubMed
Drouin, E, Russo, P, Tuchweber, B, Mitchell, G, Rasquin-Weber, A. North American Indian cirrhosis in children: a review of 30 cases. J Pediatr Gastroenterol Nutr 2000;31:395–404.CrossRefGoogle ScholarPubMed
Chagnon, P, Michaud, J, Mitchell, G, et al. A missense mutation (R565W) in cirhin (FLJ14728) in North American Indian childhood cirrhosis. Am J Hum Genet 2002;71:1443–1449.CrossRefGoogle Scholar
Carlton, VE, Harris, BZ, Puffenberger, EG, et al. Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat Genet 2003;34:91–96.CrossRefGoogle ScholarPubMed
2
Cited by

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×